Titolo	Data di pubblicazione	Autore(i)
1	Voxel-based morphometry reveals gray matter loss in patients with Paget's disease of the bone carrying SQSTM1 gene mutations	2014	Rainero I; Rubino E; D'Agata F; Rossetti S; Gastaldi L; Bergui M; Orsi L; Pinessi L; Isaia GC; Di Stefano M
2	Voxel-based Morphometry Reveals Gray Matter Loss in Patients with Paget's Disease of the Bone Carrying SQSTM1 Gene Mutations	2014	Innocenzo Rainero; Elisa Rubino; Federico D'Agata; Silvia Rossetti; Laura Gastaldi; Mauro Bergui; Laura Orsi; Lorenzo Pinessi; Giancarlo Isaia; Marco Di Stefano
3	Voxel-based Morphometry Reveals Gray Matter Abnormalities in Migraine	2008	VALFRE' W; RAINERO I; BERGUI M; PINESSI L
4	Vertebral artery dissection complicated by basilar artery occlusion successfully treated with intra-arterial thrombolysis: three case reports	2008	P. Cerrato; M. Berardino; E. Bottacchi; G. Corso; A. Lentini; G. Bosco; E. Destefanis; M. Caprioli; D. Daniele; G. B. Bradac; M. Bergui
5	Vascular Anomalies Guidelines by the Italian Society for the study of Vascular Anomalies (SISAV)	2015	Stillo, F; Baraldini, V; Dalmonte, P; El Hachem, M; Mattassi, R; Vercellio, G; Amato, B; Bellini, C; Bergui, M; Bianchini, G; Diociaiuti, A; Campisi, C; Gandolfo, C; Gelmetti, C; Moneghini, L; Monti, L; Magri, C; Neri, I; Paoloantonio, G; Patrizi, A; Rollo, M; Santecchia, L; Vaghi, M; Vercellino, N
6	Uncommon symptomatic cerebral vascular malformations	1997	M. Bergui; G. B. Bradac
7	Treatment response to interferon beta: Biological (MxA protein or IL-10 mRNA level) or MRI indicators?	2007	A. Tavella; L. Durelli; M. Clerico; P. Barbero; B. Ferrero; A. Cucci; G. Contessa; M. Bergui; E. Versino; G. Giuliani; E. Montanari
8	Treatment of cerebral arteriovenous malformations	2002	C. A. Pagni; M. Fontanella; F. Nannucci; D. Garbossa; C. Cossandi; M. Bergui; C. Nurisso; G. B. Bradac
9	Transforming growth factor beta1 (TGFbeta1) mRNA level correlates with magnetic resonance imaging disease activity in multiple sclerosis patients.	1999	BERTOLOTTO A ;CAPOBIANCO M ;MALUCCHI S ;MANZARDO E ;AUDANO L ;BERGUI M ;BRADAC GB ;MUTANI R
10	Transforming growth factor beta 1 (TGF beta 1) mRNA level correlates with magnetic resonance imaging disease activity in Multiple Sclerosis patients	1999	A. Bertolotto; M. Capobianco; S. Malucchi; E. Manzardo; L. Audano; M. Bergui; G. B. Bradac; R. Mutani
11	The OPTimization of Interferon for MS Study: 375 μg interferon beta-1b in suboptimal responders	2008	Luca Durelli; Pierangelo Barbero; Mauro Bergui; Elisabetta Versino; Marco A. Bassano; Elisabetta Verdun; Bruno Ferrero; Chiara Rivoiro; Cinzia Ferrero; Elisabetta Picco; Paolo Ripellino; Daniela Viglietti; Giorgio Giuliani; Enrico Montanari; Marinella Clerico; the OPTIMS Study Group
12	The OPTimization of interferon for MS (OPTIMS) study. A multicenter trial comparing two different doses (250 and 375 mcg) of IFN beta-1b	2004	L. Durelli; E. Verdun; P. Barbero; M. Bergui; A. Pipieri; A. Ricci; M. Clerico; A. Cucci; L. Giordano; G. B. Bradac
13	The independent comparison of interferon (incomin) trial: correlation of neutralising antibodies anti-interferon beta with clinical response and mri activity	2003	P. BARBERO; E. VERDUN; M. CLERICO; A. PIPIERI; A. RICCI; M. BERGUI; E. VERSINO; G. ANTONELLI; M. ZAFFARONI; A. GHEZZI; E. MONTANARI; L. DURELLI
14	The Independent Comparison of Interferon (INCOMIN) trial: A multicenter randomized trial comparing clinical and MRI efficacy of IFN beta-1a and beta-1b in multiple sclerosis	2001	L. Durelli; B. Ferrero; A. Ghezzi; E. Montanari; M. Zaffaroni; M. Bergui; E. Verdun; P. Barbero
15	The effect of gender on planning: An fMRI study using the Tower of London task	2006	BOGHI A; RASETTI R; AVIDANO F; MANZONE C; ORSI L; D'AGATA F; CAROPPO P; BERGUI M; ROCCA P; PULVIRENTI L; BRADAC GB; BOGETTO F; MUTANI R; MORTARA P
16	The critical patient with subarachnoid haemorrhage	2002	C. Musso; M. Bergui; M. Simonetti; D. Decaroli; M. C. Valentini; P. Costa; G. B. Bradac; G. Faccani
17	The corticotrophin-releasing hormone test is the most reliable noninvasive method to differentiate pituitary from ectopic ACTH secretion in Cushing's syndrome.	2003	G. REIMONDO; P. PACCOTTI; M. MINETTO; A. TERMINE; G. STURA; M. BERGUI; A. ANGELI; M. TERZOLO
18	Thalidomide neuropathy: clinical, electrophysiological and neuroradiological features	2004	Isoardo G; Bergui M; Durelli L; Barbero P; Boccadoro M; Bertola A; Ciaramitaro P; Palumbo A; Bergamasco B; Cocito D
19	The suddenly speechless florist on chronic dialysis: the unexpected threats of a flower shop? The diagnosis was dialysis-related Wernicke encephalopathy	2006	G. B. Piccoli; M. Burdese; E. Mezza; G. Soragna; F. Tattoli; V. Consiglio; E. Maddalena; M. Bergui; G. Scarzella; G. P. Segoloni
20	Subarachnoid hemorrhage in elderly: Advantages of the endovascular treatment.	2012	Garbossa D; Panciani PP; Fornaro R; Crobeddu E; Marengo N; Fronda C; Ducati A; Bergui M; Fontanella M.